The Safety and Efficacy of Roflumilast Foam in HS
Phase 2
20
about 2.8 years
18+
1 site in MA
What this study is about
Researchers are testing the safety and effectiveness of a new treatment called roflumilast foam for people with hidradenitis suppurativa (HS). The trial will last 1005 days and involve applying the foam to affected areas. It is investigating whether this treatment can help improve symptoms associated with HS.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Roflumilast 0.3% topical foam
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
DERMATOLOGICALS
topical
Primary: Mean Change from Baseline in Abscess and Inflammatory Nodule (AN) Count at Week 16.